NEOLEUKIN THERAPEUTICS INC - COM (NLTX)

CUSIP: 64049K104

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / COM
Total 13F shares
19,582,683
Share change
-346,655
Total reported value
$241,249,000
Put/Call ratio
104%
Price per share
$12.32
Number of holders
54
Value change
+$1,098,877
Number of buys
32
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 64049K104?
CUSIP 64049K104 identifies NLTX - NEOLEUKIN THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEOLEUKIN THERAPEUTICS INC - COM (NLTX) as of Q4 2019

As of 31 Dec 2019, NEOLEUKIN THERAPEUTICS INC - COM (NLTX) was held by 54 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,582,683 shares. The largest 10 holders included EcoR1 Capital, LLC, BAKER BROS. ADVISORS LP, Redmile Group, LLC, Opaleye Management Inc., BOXER CAPITAL, LLC, ORBIMED ADVISORS LLC, Fairmount Funds Management LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., and VANGUARD GROUP INC. This page lists 54 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.